User profiles for Andrea Zapater-Moros
Andrea Zapater-MorosEstudiante predoctoral, Hospital Universitario La Paz Verified email at estudiante.uam.es Cited by 286 |
[HTML][HTML] Comprehensive characterization of the mutational landscape in localized anal squamous cell carcinoma
…, E López-Camacho, A Zapater-Moros… - Translational …, 2020 - Elsevier
Anal squamous cell carcinoma (ASCC) is a rare neoplasm. Chemoradiotherapy is the
standard of care, with no therapeutic advances achieved over the past three decades. Thus, a …
standard of care, with no therapeutic advances achieved over the past three decades. Thus, a …
[HTML][HTML] A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
Triple-negative breast cancer is a heterogeneous disease characterized by a lack of hormonal
receptors and HER2 overexpression. It is the only breast cancer subgroup that does not …
receptors and HER2 overexpression. It is the only breast cancer subgroup that does not …
[HTML][HTML] Functional proteomics outlines the complexity of breast cancer molecular subtypes
…, G Prado-Vázquez, A Zapater-Moros… - Scientific Reports, 2017 - nature.com
Breast cancer is a heterogeneous disease comprising a variety of entities with various
genetic backgrounds. Estrogen receptor-positive, human epidermal growth factor receptor 2-…
genetic backgrounds. Estrogen receptor-positive, human epidermal growth factor receptor 2-…
[HTML][HTML] Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer
…, I Dapía, R López-Vacas, A Zapater-Moros… - Biomedicine & …, 2022 - Elsevier
The triple-negative breast cancer (TNBC) subtype comprises approximately 15% of all breast
cancers and is associated with poor long-term outcomes. Classical chemotherapy remains …
cancers and is associated with poor long-term outcomes. Classical chemotherapy remains …
[HTML][HTML] Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
…, A Gámez-Pozo, G Prado-Vázquez, A Zapater-Moros… - BMC cancer, 2019 - Springer
Background Muscle-invasive bladder tumors are associated with a high risk of relapse and
metastasis even after neoadjuvant chemotherapy and radical cystectomy. Therefore, further …
metastasis even after neoadjuvant chemotherapy and radical cystectomy. Therefore, further …
[HTML][HTML] Molecular characterization of breast cancer cell response to metabolic drugs
Metabolic reprogramming is a hallmark of cancer. It has been described that breast cancer
subtypes present metabolism differences and this fact enables the possibility of using …
subtypes present metabolism differences and this fact enables the possibility of using …
[HTML][HTML] Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
…, G Prado-Vázquez, A Zapater-Moros… - BMC cancer, 2020 - Springer
Background Metabolomics has a great potential in the development of new biomarkers in
cancer and it has experiment recent technical advances. Methods In this study, metabolomics …
cancer and it has experiment recent technical advances. Methods In this study, metabolomics …
[HTML][HTML] Urothelial cancer proteomics provides both prognostic and functional information
Traditionally, bladder cancer has been classified based on histology features. Recently, some
works have proposed a molecular classification of invasive bladder tumors. To determine …
works have proposed a molecular classification of invasive bladder tumors. To determine …
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients
A Zapater-Moros, L Díaz-Beltrán, A Gámez-Pozo… - Metabolomics, 2023 - Springer
Introduction Breast cancer is the most diagnosed tumor and the leading cause of cancer
death in women worldwide. Metabolomics allows the quantification of the entire set of …
death in women worldwide. Metabolomics allows the quantification of the entire set of …
MiRNAs in renal cell carcinoma
…, E López-Camacho, A Zapater-Moros… - Clinical and …, 2022 - Springer
MicroRNAs (miRNAs) are small RNA sequences that act as post-transcriptional regulatory
genes to control many cellular processes through pairing bases with a complementary …
genes to control many cellular processes through pairing bases with a complementary …